Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injected billions into the publicly traded market for cannabis companies. But what does this mean in terms of actual numbers for the industry's biggest players?
To quantify the market cap added to the publicly traded market for some of the bigger names in the cannabis industry, we need to calculate the difference between their market capitalizations at their public debut or the earliest available data point and their market capitalizations as of the latest available date.
Before we dive into...
Login or create a forever free account to read this news
Sign up/Log in